160
Views
33
CrossRef citations to date
0
Altmetric
Brief Report

Use of treatment guidelines in clinical decision making in bipolar disorder: a pilot survey of clinicians

Pages 467-475 | Accepted 21 Dec 2006, Published online: 25 Jan 2007

References

  • Moller HJ, Nasrallah HA. Treatment of bipolar disorder. J Clin Psychiatry 2003;64(Suppl 6):9–17
  • MacDonald ML, Naydenov A, Chu M, et al. Decrease in creatine kinase messenger RNA expression in the hippocampus and dorsolateral prefrontal cortex in bipolar disorder. Bipolar Disord 2006;8:255–64
  • Sachs GS. Strategies for improving treatment of bipolar disorder: integration of measurement and management. Acta Psychiatr Scand 2004;110(Suppl 422):7–17
  • Hadjipavlou, Mok H, Yatham LN. Bipolar II disorder: an overview of recent developments. Can J Psychiatry 2004;49: 802–12
  • Muzina DJ, Calabrese JR. Maintenance therapies in bipolar disorder: focus on randomized controlled trials. Aust N Z J Psychiatry 2005;39:652–61
  • Tohen M, Chengappa KNR, Suppes T, et al. Relapse prevention in bipolar I disorder: 18-month comparison of olanzapine plus mood stabiliser v. mood stabiliser alone. Br J Psychiatry 2004;184:337–45
  • Perlis RH. The role of pharmacologic treatment guidelines for bipolar disorder. J Clin Psychiatry 2005;66(Suppl 3): 37–47
  • Goodwin GM, for the Consensus Group of the British Association for Psychopharmacology. Evidence-based guidelines for treating bipolar disorder: recommendations from the British Association for Psychopharmacology. J Psychopharmacol 2003;17:149–73
  • Howland RH. Challenges in the diagnosis & treatment of bipolar depression. part 2: treatment options. J Psychosoc Nurs Ment Health Serv 2006;44: 9–12
  • Grunze H, Kasper S, Goodwin G, et al. The World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for the biological treatment of bipolar disorders, part III: maintenance treatment. World J Biol Psychiatry 2004;5:120–35
  • Masand PS, Fazal FS, Patkar AA. Safety considerations in pharmacotherapy of bipolar disorder. CNS Spectr 2004;9(11 Suppl 12):16–26
  • Mansell W, Colom F, Scott J. The nature and treatment of depression in bipolar disorder: a review and implications for future psychological investigation. Clin Psychol Rev 2005;25:1076–100
  • Altman S, Haeri S, Cohen LJ, et al. Predictors of relapse in bipolar disorder: A review. J Psychiatr Pract 2006;12:269–82
  • Shaneyfelt TM, Mayo-Smith MF, Rothwangl J. Are guidelines following guidelines? The methodological quality of clinical practice guidelines in the peer-reviewed medical literature. JAMA 1999;281:1900–5
  • Grunze H, Kasper S, Goodwin G, et al. The World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for the biological treatment of bipolar disorders, part II: treatment of mania. World J Biol Psychiatry 2003;4:5–13
  • Hirschfeld RMA. Guideline watch: practice guideline for the treatment of patients with bipolar disorder, 2nd ed. Arlington, Va: American Psychiatric Association. 2005. Available at: www.psych.org/psych_pract/treatg/pg/bipolar.watch.pdf. [Last accessed 29 November 2006]
  • Sachs GS, Printz DJ, Kahn DA, et al. The Expert Consensus Guideline Series: medication treatment of bipolar disorder 2000. Postgrad Med 2000 Apr;Spec No:1–104
  • American Psychiatric Association. Practice Guidelines. Available at: www.psych.org/psych_pract/treatg/pg/prac_guide.cfm. [Last accessed 29 November 2006]
  • Keck PE Jr, Perlis RH, Otto MW, Carpenter D, Ross R, Docherty JP. The Expert Consensus Guideline Series: treatment of bipolar disorder 2004. Postgrad Med Special Report 2004(December);1–120
  • Suppes T, Swann AC, Dennehy EB, et al. Texas Medication Algorithm Project: development and feasibility testing of a treatment algorithm for patients with bipolar disorder. J Clin Psychiatry 2001;62:439–47
  • Texas Department of State Health Services. TMAP Disclaimer. Available at: www.dshs.state.tx.us/mhprograms/disclaimer.shtm. [Last accessed 29 November 2006]
  • Dennehy EB, Suppes T, Rush AJ, et al. Does provider adherence to a treatment guideline change clinical outcomes for patients with bipolar disorder? Results from the Texas Medication Algorithm Project. Psychol Med 2005;35:1695–706
  • Torrey WC, Drake RE, Dixon L, et al. Implementing evidence-based practices for persons with severe mental illnesses. Psychiatr Serv 2001;52:45–50
  • West JC, Wilk JE, Olfson M, et al. Patterns and quality of treatment for patients with schizophrenia in routine psychiatric practice. Psychiatr Serv 2005;56:283–91
  • Goethe JW, Schwartz HI, Szarek BL. Physician compliance with practice guidelines. Conn Med 1997;61:553–8
  • Lieberman JA, Stroup TS, McEvoy JP, et al. Effectiveness of antipsychotic drugs in patients with chronic schizophrenia. N Engl J Med 2005;353:1209–23
  • Chassin MR, Kosecoff J, Park RE, et al. Does inappropriate use explain geographic variations in the use of health care services? A study of three procedures. JAMA 1987;258:2533–7
  • Woolf SH. Practice guidelines: a new reality in medicine. I. Recent developments. Arch Intern Med 1990;150:1811–18
  • Berg AO, Atkins D, Tierney W. Clinical practice guidelines in practice and education. J Gen Intern Med 1997;12(Suppl 2): S25–33
  • American Psychiatric Association. Practice guideline for the treatment of patients with bipolar disorder (revision). Am J Psychiatry 2002;159(Suppl 4):1–50
  • Zarin DA, Young JL, West JC. Challenges to evidence-based medicine: a comparison of patients and treatments in randomized controlled trials with patients and treatments in a practice research network. Soc Psychiatry Psychiatr Epidemiol 2005;40:27–35
  • Peipert JF, Hogan JW, Gifford D, Chase E, Randall R. Strength of indication for cesarean delivery: comparison of private physician versus resident service labor management. Am J Obstet Gynecol 1999;181:435–9
  • Citrome L, Stroup TS. Schizophrenia, Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) and number needed to treat: how can CATIE inform clinicians? Int J Clin Pract 2006;60:933–40

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.